Pharmaceutical firm Lupin has reported a consolidated net profit of Rs 266 crore in the second quarter of FY12, a growth of 23.7% as compared to Rs 215 crore in the corresponding quarter of last fiscal.
Consolidated revenues are seen going up 21.41% to Rs 1,741 crore from Rs 1,434 crore during the same period.
Topline as well as bottomline numbers were better than expectations; CNBC-TV18 poll saw net profit at Rs 223.3 crore and revenues at Rs 1,646 crore during the quarter ended September FY12.
Source: www.moneycontrol.com
Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd
No comments:
Post a Comment